Trulieve Opens Dunwoody Dispensary, Expands Metro Atlanta Footprint

Dunwoody Store Details

The Dunwoody dispensary operates seven days a week with extended hours and a drive-thru lane for registered patients. Store hours run Monday through Saturday 9 a.m. to 8 p.m., Sunday 10 a.m. to 6 p.m. Private consultation rooms staffed by pharmacists and patient educators occupy part of the facility.

Trulieve's product menu includes low-THC oil tinctures, capsules, topicals, and vaporizer cartridges manufactured at the company's Adel, Georgia cultivation and processing facility. Georgia law caps THC content at 5 percent by weight for registered patients.

Metro Atlanta Expansion Strategy

Trulieve now operates two dispensaries in metro Atlanta following the July 2026 opening of its Marietta location. The MSO holds one of six Class 1 production licenses issued by the Georgia Access to Medical Cannabis Commission in 2021. Each Class 1 license permits up to five retail dispensaries statewide.

The company's Georgia footprint includes:

• 125,000-square-foot cultivation and processing facility in Adel (operational since March 2024)
• Marietta dispensary (opened July 2026)
• Dunwoody dispensary (opened September 2026)
• Three additional retail licenses available for future deployment

For full background on this story, see the CannIntel topic hub on Georgia Medical Cannabis Program.

Georgia Patient Registry Growth

Georgia's medical cannabis registry enrolled 34,800 patients as of August 2026, up 18 percent from 29,500 in December 2025. The Georgia Department of Public Health reports average monthly enrollment of 750 new patients since the first dispensaries opened in spring 2024.

Qualifying conditions expanded in May 2025 to include chronic pain, migraines, and opioid use disorder. That regulatory change drove a 41 percent surge in new patient applications between June and December 2025, according to DPH data.

Competitive Landscape in Metro Atlanta

Five of Georgia's six licensed producers now operate dispensaries in metro Atlanta, concentrating retail access in the state's largest population center. Competitors include:

• Botanical Sciences (two locations: Sandy Springs, Buckhead)
• Natures GA (one location: Decatur)
• Theratrue (one location: Roswell)
• FFD GA Holdings (one location: Atlanta)

Treevana Remedy, the sixth licensee, operates a cultivation facility in Dublin but hasn't yet opened retail locations. Metro Atlanta accounts for 62 percent of Georgia's registered medical cannabis patients, per Georgia Access to Medical Cannabis Commission filings.

Revenue and Operational Context

Trulieve reported $1.3 billion in total revenue for fiscal 2025, with Georgia operations contributing an undisclosed amount classified under "emerging markets." The MSO operates 207 dispensaries across 11 states. Florida accounts for 68 percent of total revenue in Q2 2026.

Georgia's medical cannabis market remains supply-constrained. The state issued no new production licenses beyond the original six awarded in 2021, and legislative efforts to expand the program stalled in the 2026 session. Industry observers expect total Georgia medical cannabis sales to reach $45 million to $55 million in 2026, based on patient count and average monthly purchase data from established programs in similar-sized states.